We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.59B
AUM Growth
-$234M
Cap. Flow
-$159M
Cap. Flow %
-6.14%
Top 10 Hldgs %
45.98%
Holding
325
New
10
Increased
161
Reduced
104
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWS icon
276
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$204K 0.01%
1,953
WCLD
277
WisdomTree Cloud Computing Fund
WCLD
$279M
$202K 0.01%
6,824
PSA icon
278
Public Storage
PSA
$60.9B
$201K 0.01%
764
+11
+1% +$3.08K
ECBK icon
279
ECB Bancorp
ECBK
$180M
$171K 0.01%
+15,555
New +$191K
CGBD icon
280
Carlyle Secured Lending
CGBD
$713M
$169K 0.01%
11,623
GBDC icon
281
Golub Capital BDC
GBDC
$3.44B
$163K 0.01%
11,096
CRF
282
Cornerstone Total Return Fund
CRF
$1.15B
$162K 0.01%
20,735
+711
+4% +$5.68K
ADMA icon
283
ADMA Biologics
ADMA
$2.03B
$162K 0.01%
45,267
INVA icon
284
Innoviva
INVA
$1.53B
$161K 0.01%
12,359
+147
+1% +$1.91K
GLAD icon
285
Gladstone Capital
GLAD
$430M
$156K 0.01%
8,077
+245
+3% +$5.07K
FLG
286
Flagstar Bank National Association
FLG
$5.93B
$154K 0.01%
+4,522
New +$164K
CLM icon
287
Cornerstone Strategic Value Fund
CLM
$2.2B
$147K 0.01%
18,589
-4,271
-19% -$35.2K
HBAN icon
288
Huntington Bancshares
HBAN
$35.1B
$139K 0.01%
13,348
+43
+0.3% +$482
VLY icon
289
Valley National Bancorp
VLY
$8.02B
$124K ﹤0.01%
14,500
MUJ icon
290
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$637M
$106K ﹤0.01%
+10,490
New +$114K
NAK
291
Northern Dynasty Minerals
NAK
$818M
$104K ﹤0.01%
318,950
IOVA icon
292
Iovance Biotherapeutics
IOVA
$1.93B
$67.2K ﹤0.01%
14,771
-462
-3% -$3.02K
HRTX icon
293
Heron Therapeutics
HRTX
$96.8M
$50.4K ﹤0.01%
48,979
+1,175
+2% +$1.67K
ISPC icon
294
iSpecimen
ISPC
$2.89M
$34.8K ﹤0.01%
70
-12
-15% -$10.6K
VOR icon
295
Vor Biopharma
VOR
$1.16B
$29.6K ﹤0.01%
699
+18
+3% +$976
REKR icon
296
Rekor Systems
REKR
$90M
$28.2K ﹤0.01%
+10,000
New +$30.5K
RBBN icon
297
Ribbon Communications
RBBN
$373M
$26.9K ﹤0.01%
10,030
FUBO icon
298
FuboTV Inc
FUBO
$283M
$26.8K ﹤0.01%
838
+5
+0.6% +$155
MRSN
299
DELISTED
Mersana Therapeutics
MRSN
$20.5K ﹤0.01%
645
+15
+2% +$713
IBRX icon
300
ImmunityBio
IBRX
$7.49B
$16.9K ﹤0.01%
10,000

Similar funds

Grimes & Company's Q3 2023 Portfolio in Review

As of Q3 2023, Grimes & Company held 325 positions worth $2.59B, down 8.3% from $2.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Grimes & Company withdrew a net $159M in Q3 2023, closing 15 positions and reducing 104 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $1.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in DocuSign worth $12M.

  • Grimes & Company's largest Q3 2023 buy was DocuSign: 286,831 shares worth $12M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q3 2023, an estimated $58.1M increase.
  • Grimes & Company's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $82.8M.
  • Grimes & Company fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2023, selling an estimated $1.9M.
  • Grimes & Company's ten largest holdings make up 46% of its $2.59B portfolio in Q3 2023.
  • Grimes & Company opened 10 new positions and closed 15 in Q3 2023.
  • Grimes & Company's portfolio value fell 8.3% quarter-over-quarter to $2.59B.

Based on Grimes & Company's 13F filing for Q3 2023, filed 19 Oct 2023.